Predictive value of autoantibody testing for validating self-reported diagnoses of rheumatoid arthritis in the women's health initiative

American Journal of Epidemiology

Volumn 177, Issue 9, 2013, Pages 887-893

  Walitt, Brian ^a   MacKey, Rachel ^b   Kuller, Lewis ^b   Deane, Kevin D ^e   Robinson, William ^d   Holers, V Michael ^e   Chang, Yue Fang ^c   Moreland, Larry ^c  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

anti cyclic citrullinated peptide antibody; diagnostic validation; rheumatoid arthritis; rheumatoid factor

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; RHEUMATOID FACTOR;

ANTIBODY; COHORT ANALYSIS; DISEASE CONTROL; DISEASE PREVALENCE; HEALTH CARE; MEASUREMENT METHOD; PEPTIDE; SERUM; WOMENS HEALTH;

ADULT; ANTIBODY DETECTION; ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; POSTMENOPAUSE; PREDICTIVE VALUE; PREVALENCE; RHEUMATOID ARTHRITIS; SELF REPORT; VALIDATION STUDY; WOMEN'S HEALTH;

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DIAGNOSTIC VALIDATION; RHEUMATOID ARTHRITIS; RHEUMATOID FACTOR;

ANTIBODIES, ANTI-IDIOTYPIC; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; PEPTIDES, CYCLIC; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RHEUMATOID FACTOR; SELF REPORT; WOMEN'S HEALTH;

EID: 84877254039     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws310     Document Type: Article

References (25)

1. Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9): 2569-2581.
2. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31(3):315-324.
3. Karlson EW, Lee IM, Cook NR, et al. Comparison of self-reported diagnosis of connective tissue disease with medical records in female health professionals: the Women's Health Cohort Study. Am J Epidemiol. 1999;150(6):652-660.
4. Costenbader KH, Feskanich D, Mandl LA, et al. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. Am J Med. 2006;119(6):503e1-503e9.
5. Walitt BT, Constantinescu F, Katz JD, et al. Validation of self-report of rheumatoid arthritis and systemic lupus erythematosus: The Women's Health Initiative. J Rheumatol. 2008;35(5):811-818.
6. Hays J, Hunt JR, Hubbell FA, et al. The Women's Health Initiative recruitment methods and results. Ann Epidemiol. 2003;13(suppl 9):S18-S77.
7. Formica MK, McAlindon TE, Lash TL, et al. Validity of self-reported rheumatoid arthritis in a large cohort: results from the Black Women's Health Study. Arthritis Care Res. 2010; 62(2):235-241.
8. Solomon DH, Ayanian JZ, Yelin E, et al. Use of disease-modifying medications for rheumatoid arthritis by race and ethnicity in the National Ambulatory Medical Care Survey. Arthritis Care Res. 2012;64(2):184-189.
9. Mierau R, Genth E. Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis. Clin Chem Lab Med. 2006;44(2):138-143.
10. Steiner G. Auto-antibodies and autoreactive T-cells in rheumatoid arthritis: pathogenetic players and diagnostic tools. Clin Rev Allergy Immunol. 2007;32(1):23-36.
11. Raptopoulou A, Sidiropoulos P, Katsouraki M, et al. Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts. Crit Rev Clin Lab Sci. 2007;44(4):339-363.
12. Coenen D, Verschueren P, Westhovens R, et al. Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis. Clin Chem. 2007;53(3):498-504
13. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials. 1998;19(1):61-109.
14. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333.
15. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291(14):1701-1712.
16. Stefanick ML, Cochrane BB, Hsia J, et al. The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants. Ann Epidemiol. 2003;13(suppl 9):S78-S86.
17. Kolfenbach JR, Deane KD, Derber LA, et al. Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis. Arthritis Rheum. 2011;62(9):2633-2639.
18. Mikuls TR, Holers VM, Parrish L, et al. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in African Americans with early rheumatoid arthritis. Arthritis Rheum. 2006;54(9):3057-3059.
19. Majka DS, Deane KD, Parrish LA, et al. Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis. Ann Rheum Dis. 2008;67(6):801-807.
20. Kolfenbach JR, Deane KD, Derber LA, et al. A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA. Arthritis Rheum. 2009;61(12):1735-1742.
21. Annotated bibliography appendices: international codes of ethics. Bull Pan Am Health Organ. 1990;24(4):582-629.
22. Wolfe F, Michaud K, Gefeller O, et al. Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum. 2003; 48(6):1530-1542.
23. Whiting PF, Smidt N, Sterne JA, et al. Systematic review: accuracy of anti-citrullinated peptide antibodies for diagnosing rheumatoid arthritis. Ann Intern Med. 2010;152(7):456-464.
24. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41(5): 778-799.
25. Kvien TK, Glennas A, Knudsrod OG, et al. The prevalence and severity of rheumatoid arthritis in Oslo. Results from a county register and a population survey. Scand J Rheumatol. 1997;26(6):412-418.